Ozempic constipation symptom guide

Ozempic constipation: current label rates and warning signs

Review constipation during Ozempic care using current injection and tablet labeling, including product-specific trial rates, bowel-obstruction warning signs, medication review, and compounded-product distinctions.

Educational guideUpdated August 13, 2026

A product-first constipation check during Ozempic care

Identify the exact product and route: Ozempic weekly injection, Ozempic daily tablets, another semaglutide product, or a patient-specific compounded prescription.

Describe what changed: bowel-movement frequency, stool hardness, straining, incomplete emptying, bloating, pain, and whether stool and gas still pass.

Record onset, duration, severity, food and fluid intake, urine output, and timing relative to treatment, a clinician-directed change, refill, illness, travel, or another medicine.

Contact the prescriber before changing Ozempic or adding a laxative, fiber product, magnesium product, enema, suppository, or supplement.

Use prompt in-person care for severe abdominal, obstruction-like, dehydration, bleeding, neurologic, or other emergency warning signs.

Direct answer

Constipation is a common Ozempic adverse reaction, but the rate depends on the formulation and study. In pooled placebo-controlled trials of Ozempic weekly injection, constipation occurred in 5% with 0.5 mg and 3.1% with 1 mg, versus 1.5% with placebo. The current combined Ozempic and Rybelsus tablet label reports constipation in 6% with semaglutide 7 mg and 5% with 14 mg, versus 2% with placebo; those older tablet trial strengths do not establish a rate for every current Ozempic tablet strength. Contact the prescriber for persistent, worsening, painful, or function-limiting constipation. Severe or persistent abdominal pain, repeated vomiting, marked swelling, inability to pass stool or gas, blood or black stool, fainting, confusion, or inability to keep fluids down needs prompt in-person assessment.

Current injection-label answer

Ozempic injection trials report separate rates by strength

The current Novo Nordisk Ozempic injection label, effective June 1, 2026, lists constipation among the most common adverse reactions. In two pooled placebo-controlled trials in people with type 2 diabetes, constipation was reported in 5% of participants receiving Ozempic 0.5 mg and 3.1% receiving Ozempic 1 mg, versus 1.5% receiving placebo. These percentages belong to those studied groups and strengths; they do not predict one person’s cause, severity, duration, or response.

Keep each injection percentage tied to its labeled study strength: 0.5 mg, 1 mg, or placebo.
Do not average the strength groups, transfer a Wegovy rate, or present one number as a universal Ozempic constipation rate.
The label does not provide one expected constipation duration or prove that Ozempic caused every individual bowel change.

Tablet evidence boundary

Current Ozempic tablet strengths and the published safety table are not the same strength system

The current combined Ozempic and Rybelsus tablet label includes once-daily oral semaglutide and reports constipation in 6% with semaglutide 7 mg and 5% with 14 mg, versus 2% with placebo, in the displayed placebo-controlled trial table. The label explains that safety for the current Ozempic 1.5 mg, 4 mg, and 9 mg tablet strengths is established from the oral semaglutide program. The table therefore supports constipation as a recognized tablet adverse reaction, but it is not a strength-specific rate table for every current Ozempic tablet presentation.

Confirm whether the prescription is Ozempic injection or Ozempic tablets before interpreting a percentage or administration routine.
Do not treat 7 mg or 14 mg trial percentages as current 1.5 mg, 4 mg, or 9 mg Ozempic tablet strength-specific rates.
Do not transfer injection timing, missed-dose, storage, or trial-rate instructions to tablets, or tablet routines to an injection.

Symptom pattern and urgency

Routine bowel changes and obstruction-like symptoms need different pathways

Constipation can mean fewer bowel movements, harder stools, straining, incomplete emptying, or a meaningful change from a person’s usual pattern. Current Ozempic injection and tablet labels also list postmarketing reports of ileus, intestinal obstruction, and severe constipation including fecal impaction. Because those reports are voluntary and come from a population of uncertain size, they do not provide a reliable frequency or prove Ozempic caused an individual event. They do support taking severe, progressive, or obstruction-like symptoms seriously.

Record the last bowel movement, stool consistency, ability to pass gas, abdominal swelling, pain location and severity, nausea or vomiting, fever, bleeding, intake, and urine output.
Contact the prescriber for a persistent or worsening change, painful bowel movements, marked straining, symptoms after a refill or clinician-directed change, or constipation that affects normal activity.
Seek prompt in-person assessment for severe or persistent abdominal pain, repeated vomiting, marked swelling or a rigid abdomen, inability to pass stool or gas, blood or black stool, fainting, confusion, severe weakness, or inability to keep fluids down.

Medication and medical review

Other medicines, low intake, and prior bowel conditions may change the assessment

A bowel-pattern change may overlap with reduced food or fluid intake, travel, illness, pregnancy, a prior gastrointestinal condition, or another medicine. Opioid pain medicines, iron, some antacids, anticholinergic medicines, some antidepressants, antihistamines, and other products can contribute to constipation. A clinician should review the full pattern instead of assuming Ozempic is the only possible cause or automatically recommending the same remedy to everyone.

Share prior constipation, bowel obstruction or surgery, hernia, severe gastroparesis, kidney or heart disease, pregnancy possibility, recent illness, and meaningful changes in food, fluid, activity, or weight.
List every prescription, over-the-counter medicine, vitamin, mineral, fiber product, laxative, antacid, pain medicine, antihistamine, supplement, alcohol product, and cannabis product.
Do not combine laxatives, use repeated enemas, start a “detox,” or follow a forum clean-out plan without individualized clinician or pharmacist guidance.

Product identity and follow-up

Ozempic data do not establish a compounded-semaglutide constipation rate

Ozempic injection and Ozempic tablets are FDA-approved finished semaglutide products with formulation-specific strengths, routines, presentations, and evidence. A patient-specific compounded semaglutide preparation is not FDA-approved Ozempic or an FDA-approved generic Ozempic finished product and may differ in concentration, inactive ingredients, container, labeling, storage, and beyond-use date. For non-emergency constipation, the prescriber can review symptoms, hydration, nutrition, other medicines, medical history, and the exact product before deciding whether examination, testing, a bowel plan, or a treatment change is appropriate.

Bring the product name, route, strength or concentration, manufacturer or dispensing pharmacy, refill or lot details, storage history, and a photo of the current label.
Do not skip, repeat, stop, restart, split, increase, decrease, switch, or convert Ozempic based on a generic constipation guide.
Avoid research-use products, counterfeit pens or tablets, unlabeled vials, copied syringe or bowel-cleanout charts, and no-prescription sellers.

Patient safety checklist

Questions to ask about constipation during Ozempic care

These points are educational and do not replace medical advice. A licensed clinician should review individual history, medications, risks, and state-specific availability before treatment.

✓

Which exact product and route am I using: Ozempic injection, Ozempic tablets, another semaglutide product, or a patient-specific compounded prescription?

✓

What changed from my usual bowel pattern, when did it start, when was my last bowel movement, and can I still pass gas?

✓

Do I have severe or persistent pain, marked abdominal swelling, repeated vomiting, fever, blood or black stool, dizziness, fainting, confusion, reduced urination, or inability to keep fluids down?

✓

Did symptoms follow treatment, a clinician-directed change, a refill, illness, travel, reduced intake, another medicine, or a new supplement?

✓

Could opioids, iron, antacids, antihistamines, antidepressants, anticholinergic medicines, laxatives, fiber, magnesium, or another product change the assessment?

✓

Do prior bowel obstruction or surgery, severe gastroparesis, hernia, kidney or heart disease, pregnancy possibility, or another condition change the safest plan?

✓

Which individualized food, fluid, activity, or bowel-product steps are appropriate, and when should I report that they are not working?

✓

Who should I contact before the next treatment or refill, and which symptoms should bypass messaging for urgent or emergency assessment?

FAQs

Short answers for patients

Does Ozempic cause constipation?

Constipation is a recognized common adverse reaction in current Ozempic injection and tablet labeling. A label association does not prove Ozempic caused one person’s bowel change, so product identity, timing, severity, intake, other medicines, and warning signs still need review.

How common is constipation with Ozempic injection?

In pooled placebo-controlled trials, constipation occurred in 5% with Ozempic 0.5 mg and 3.1% with Ozempic 1 mg, versus 1.5% with placebo. Keep those percentages tied to the studied injection strengths and populations rather than combining them into one rate.

How common is constipation with Ozempic tablets?

The current combined tablet label displays constipation rates of 6% with semaglutide 7 mg and 5% with 14 mg, versus 2% with placebo. Those trial strengths do not establish separate constipation rates for every current Ozempic tablet strength.

How long does Ozempic constipation last?

The current labels do not provide one expected duration. Record onset, duration, severity, exact formulation, bowel pattern, food and fluid intake, other symptoms, refill or treatment-change timing, and other medicines. Contact the prescriber for persistent, painful, recurrent, worsening, or function-limiting symptoms.

Can I take a laxative with Ozempic?

Ask the responsible clinician or pharmacist before adding or combining laxatives. Severe pain, vomiting, inability to pass gas, marked swelling, bleeding, kidney or heart disease, pregnancy, fluid restrictions, other medicines, and the possible cause can change which options are appropriate or whether examination is needed first.

Should I skip Ozempic if I am constipated?

Do not skip, repeat, stop, restart, split, or change Ozempic based on generic online advice. Contact the responsible prescriber with the bowel pattern, other symptoms, intake, medicines, and product details before the next treatment decision. Urgent warning signs require in-person assessment.

Does Ozempic constipation guidance apply to compounded semaglutide?

Not automatically. A patient-specific compounded preparation is not FDA-approved Ozempic and may differ in concentration, inactive ingredients, presentation, labeling, storage, and beyond-use date. Ozempic trial rates do not establish a constipation incidence for a compounded preparation.

When is constipation during Ozempic care urgent?

Seek prompt in-person care for severe or persistent abdominal pain, repeated vomiting, marked abdominal swelling or rigidity, inability to pass stool or gas, blood or black stool, fainting, confusion, severe weakness, markedly reduced urination, or inability to keep fluids down.

Sources and related reading

Peptide12 pages use conservative educational language and authoritative sources where possible.

DailyMed: Novo Nordisk OZEMPIC injection prescribing information — effective June 1, 2026 DailyMed: Current OZEMPIC and RYBELSUS tablet prescribing information MedlinePlus: Semaglutide injection drug information — revised May 15, 2026 MedlinePlus: Constipation FDA: Compounding and the FDA — Questions and Answers Peptide12: Ozempic Peptide12: Compounded semaglutide injection Peptide12: Ozempic injection side effects Peptide12: Ozempic and dehydration Peptide12: Semaglutide constipation Peptide12: GLP-1 constipation Peptide12: Constipation medicines and peptide care Peptide12: When to message your clinician Peptide12: How online peptide therapy works